Allogene Therapeutics Inc (ALLO)
3.01
-0.06
(-1.95%)
USD |
NASDAQ |
May 06, 14:58
Allogene Therapeutics Shares Outstanding: 169.09M for March 12, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 12, 2024 | 169.09M |
December 31, 2023 | 168.64M |
October 31, 2023 | 168.28M |
September 30, 2023 | 168.18M |
July 31, 2023 | 167.63M |
June 30, 2023 | 167.13M |
May 01, 2023 | 145.84M |
April 17, 2023 | 145.78M |
March 31, 2023 | 145.74M |
February 24, 2023 | 144.50M |
December 31, 2022 | 144.44M |
October 31, 2022 | 144.21M |
September 30, 2022 | 144.03M |
August 05, 2022 | 143.81M |
June 30, 2022 | 143.72M |
May 02, 2022 | 143.60M |
April 18, 2022 | 143.60M |
March 31, 2022 | 143.57M |
February 21, 2022 | 142.75M |
December 31, 2021 | 142.62M |
November 02, 2021 | 142.52M |
September 30, 2021 | 142.44M |
August 02, 2021 | 142.18M |
June 30, 2021 | 142.12M |
May 03, 2021 | 141.54M |
Date | Value |
---|---|
April 12, 2021 | 141.49M |
March 31, 2021 | 141.47M |
February 22, 2021 | 140.65M |
December 31, 2020 | 140.47M |
November 02, 2020 | 140.28M |
September 30, 2020 | 139.76M |
August 03, 2020 | 139.29M |
June 30, 2020 | 139.23M |
June 04, 2020 | 138.79M |
May 04, 2020 | 125.33M |
April 21, 2020 | 125.31M |
March 31, 2020 | 125.26M |
February 24, 2020 | 124.91M |
December 31, 2019 | 124.27M |
November 01, 2019 | 121.90M |
September 30, 2019 | 121.90M |
August 02, 2019 | 121.75M |
June 30, 2019 | 121.63M |
May 03, 2019 | 121.54M |
April 22, 2019 | 121.53M |
March 31, 2019 | 121.53M |
March 15, 2019 | 121.53M |
March 04, 2019 | 121.48M |
December 31, 2018 | 121.48M |
November 15, 2018 | 121.48M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
121.63M
Minimum
Jun 30 2019
169.09M
Maximum
Mar 12 2024
142.13M
Average
142.44M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Agenus Inc | 20.95M |
ANI Pharmaceuticals Inc | 21.07M |
Vaxart Inc | 173.86M |
aTyr Pharma Inc | 67.75M |
PAVmed Inc | 9.172M |